Especially in CRC, precision medicine predicts patient responses to specific treatments by identifying particularly genetic mutations, such as KRAS, BRAF, and PIK3CA, while also reducing unnecessary treatment side effects (8). The gene discussed is KRAS; the disease is colorectal carcinoma.